OPTIMIZATION OF METASTATIC COLORECTAL CANCER TREATMENT WITH RAS MUTATIONS

Current knowledge concerning impact of certain mutations on targeted therapy efficacy underlines the necessity to perform genetical analysis in order to choose appropriate treatment. Panitumumab addition to 1st line metastatic colorectal cancer chemotherapy in patients with wild-type RAS allows to a...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Autor principal: L. V. Bolotina
Formato: Artigo
Idioma:Russo
Publicado em: “ABV-press” Publishing house”, LLC 2015-02-01
Colecção:Тазовая хирургия и онкология
Assuntos:
colorectal cancer
ras mutation
panitumumab
Acesso em linha:https://ok.abvpress.ru/jour/article/view/90
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados